Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5588254 | Journal of Diabetes and its Complications | 2017 | 33 Pages |
Abstract
In T2D patients with HT, eGFR reduction and albuminuria are independently associated with a greater risk of developing stage 3 CKD. While baseline albuminuria entails a greater renal risk, due to a larger occurrence of the non-albuminuric phenotype, renal function worsening is more likely to be observed in patients without albuminuria.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Francesca Viazzi, Pamela Piscitelli, Carlo Giorda, Antonio Ceriello, Stefano Genovese, Giuseppina T. Russo, Paola Fioretto, Pietro Guida, Salvatore De Cosmo, Roberto Pontremoli, AMD-Annals Study Group AMD-Annals Study Group,